Product Information
EMSAM 12 MG/24 HOURS PATCH is a brand product labeled by Viatris Specialty LLC, priced at $75.3981 per EA under NDC 49502090230. Its NADAC has been published 293 times since Nov 28, 2013.
FDA first approved this application on Feb 27, 2006.
Strength
12 mg/24h
Manufacturer
Viatris Specialty LLCNDC
49502090230
Classification
Brand
Dosage Form
PATCH
Route
TRANSDERMAL
Effective Date
9/23/2026
Active Ingredients
SELEGILINEApproval Type
New Drug (NDA)
FDA Application
NDA021336FDA Approved
2/27/2006
On Market Since
2/27/2006
Pharmacological Classes
Price Statistics
The NADAC for EMSAM 12 MG/24 HOURS PATCH has been published 293 times since Nov 28, 2013, and over the history we have for it it has risen 131.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $75.3981 per EA |
|---|---|
| All-time high | $75.6819 (Jun 10, 2026) |
| All-time low | $31.8528 (Jan 22, 2014) |
| 52-week high | $75.6819 |
| 52-week low | $71.7213 |
| Median price | $48.5804 |
| Average price | $54.5555 |
| Largest weekly change | +41.9% (May 22, 2024) |
| Weeks tracked | 293 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the selegiline market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Viatris Specialty LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
selegiline market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Monoamine Oxidase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of EMSAM 12 MG/24 HOURS PATCH?
The current National Average Drug Acquisition Cost (NADAC) for EMSAM 12 MG/24 HOURS PATCH, manufactured by Viatris Specialty LLC, is $75.3981 per EA (NDC 49502090230), effective Sep 30, 2026.
How has the price of EMSAM 12 MG/24 HOURS PATCH changed over time?
Over the history we have for it, the NADAC for EMSAM 12 MG/24 HOURS PATCH has risen 131.8%. It has been tracked across 293 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for EMSAM 12 MG/24 HOURS PATCH?
Since Nov 28, 2013, the NADAC for EMSAM 12 MG/24 HOURS PATCH has ranged from a low of $31.8528 (Jan 22, 2014) to a high of $75.6819 (Jun 10, 2026), with a median of $48.5804 per EA.
Are there cheaper alternatives to EMSAM 12 MG/24 HOURS PATCH?
No other NADAC-published product currently shares the active ingredient and strength of EMSAM 12 MG/24 HOURS PATCH in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures EMSAM 12 MG/24 HOURS PATCH?
EMSAM 12 MG/24 HOURS PATCH (NDC 49502090230) is labeled by Viatris Specialty LLC, and CMS classifies it as a brand product.